Suppr超能文献

肺动脉高压患者行二尖瓣和三尖瓣手术的结局预测因素。

Predictors of Outcome in Patients with Pulmonary Hypertension Undergoing Mitral and Tricuspid Valve Surgery.

机构信息

Department of Cardiac Surgery, St. Thomas Hospital London, London SE1 7EH, UK.

Department of Cardiology, St. Thomas Hospital London, London SE1 7EH, UK.

出版信息

Medicina (Kaunas). 2023 Jun 7;59(6):1103. doi: 10.3390/medicina59061103.

Abstract

: Pulmonary hypertension (PH) secondary to left-sided valvular heart disease is associated with poor cardiac surgical outcome compared with patients without PH. Our objective was to investigate the prognostic factors of surgical outcome in patients with PH undergoing mitral valve (MV) and tricuspid valve (TV) surgery, in order to risk stratify their management. : This is a retrospective observational study on patients with PH who underwent MV and TV surgery from 2011 to 2019. The primary outcome was all-cause mortality. The secondary outcomes were post-op respiratory and renal complications, length of intensive care unit stay and length of hospital stay. : Seventy-six patients were included in this study. The all-cause mortality was 13% ( = 10), with mean survival of 92.6 months. Among the patients, 9.2% ( = 7) had post-op renal failure requiring renal replacement therapy and 6.6% ( = 5) had post-op respiratory failure requiring intubation. Univariate analysis demonstrated that pre-operative left ventricular ejection fraction (LVEF), peak systolic tissue velocity at the tricuspid annulus (S') and etiology of MV disease were associated with respiratory and renal failure. Tricuspid annular plane systolic excursion (TAPSE) was associated with respiratory failure only. S', type of operation, LVEF, urgency of surgery, and etiology of MV disease were found to be predictive of mortality. After excluding redo mitral surgery, all statistically significant findings remain unchanged, with the addition of right ventricular (RV) size being associated with respiratory failure. In the subgroup analysis of routine cases ( = 56), patients with primary mitral regurgitation who underwent mitral valve repair had better survival outcome. : Urgency of surgery, etiology of MV disease, type of operation (replacement or repair), S' and pre-op LVEF are prognostic indicators in this small cohort of patients with PH undergoing MV and TV surgery. A larger prospective study is warranted to validate our findings.

摘要

: 与无肺动脉高压(PH)的患者相比,由左侧瓣膜性心脏病引起的肺动脉高压与心脏手术结局不良相关。我们的目的是研究 PH 患者行二尖瓣(MV)和三尖瓣(TV)手术后手术结果的预后因素,以便对其进行风险分层管理。: 这是一项回顾性观察性研究,纳入了 2011 年至 2019 年期间行 MV 和 TV 手术的 PH 患者。主要结局是全因死亡率。次要结局是术后呼吸和肾脏并发症、重症监护病房住院时间和住院时间。: 本研究共纳入 76 例患者。全因死亡率为 13%(=10),平均生存时间为 92.6 个月。其中,9.2%(=7)的患者术后发生需要肾脏替代治疗的肾衰竭,6.6%(=5)的患者术后发生需要插管的呼吸衰竭。单因素分析表明,术前左心室射血分数(LVEF)、三尖瓣环收缩期组织速度峰值(S')和 MV 疾病的病因与呼吸和肾衰竭相关。三尖瓣环平面收缩期位移(TAPSE)仅与呼吸衰竭相关。S'、手术类型、LVEF、手术紧迫性和 MV 疾病的病因与死亡率相关。排除二尖瓣再手术患者后,所有有统计学意义的发现仍然不变,此外,右心室(RV)大小与呼吸衰竭相关。在常规病例的亚组分析中(=56),行二尖瓣修复术的原发性二尖瓣关闭不全患者的生存结局更好。: 手术紧迫性、MV 疾病的病因、手术类型(置换或修复)、S'和术前 LVEF 是该小队列 PH 患者行 MV 和 TV 手术后的预后指标。需要更大规模的前瞻性研究来验证我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a27c/10302326/1076e54043b3/medicina-59-01103-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验